Indivior Pharmaceuticals Inc Ordinary Share INDV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $40.23
- Day Range
- $39.58–41.53
- 52-Week Range
- $15.00–42.81
- Bid/Ask
- $39.95 / $41.74
- Shares Outstanding
- 118.20M
- Market Cap
- $4.84B
- Volume/Avg
- 2M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 18.61
- Price/Sales
- 4.09
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 2.58%
Company Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 838
- Website
- https://www.indivior.com
Valuation
|
Metric
|
INDV
|
|---|---|
Price/Earnings (Normalized) | 18.61 |
Price/Book Value | — |
Price/Sales | 4.09 |
Price/Cash Flow | 16.09 |
Price/Earnings
INDV
Financial Strength
|
Metric
|
INDV
|
|---|---|
Quick Ratio | 0.59 |
Current Ratio | 0.86 |
Interest Coverage | 7.85 |
Quick Ratio
INDV
Profitability
|
Metric
|
INDV
|
|---|---|
Return on Assets (Normalized) | 23.77% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 173.19% |
Return on Assets
INDV
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|&GQR&h< | LOCK|##T& | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|frkYH& | LOCK|?sW | $42B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|?<>SZ@?b | LOCK|wMNCx | $37B | |||
| Zoetis Inc Class A
ZTS
| LOCK|h?@mll@y | LOCK|BFf | $31B | |||
| Viatris Inc
VTRS
| LOCK|bN><@lG | LOCK|RW! | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|s% | LOCK|c@< | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Tnbh%Y | LOCK|lg | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^fQ&W?r | LOCK|<Pw | $9B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|>@WkYy | LOCK|%mF# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|KY@VvX | LOCK|m! | $1B |
United States